The Latest Breaking News from Cardiology

The process of hiring new specialists has been protracted partly because of legal issues.

Cardiologists pen an explosive letter to ACT Health Minister Rachel Stephen-Smith over "unacceptable and dangerous" cardiology care at the Canberra Hospital.

Some heart medications are contraindicated for use with Paxlovid, a new study in the Journal of the American College of Cardiology says.

A dearth of specialists and infrastructure in India, in the government and private sectors, is hampering the future of children with congenital heart disease

KASARAGOD

Studies show that women with heart disease are more likely to be misdiagnosed than men, and will have worse outcomes for surgery. What is behind this bias and how can how it be fixed?

Heather Jacobs has heart failure and angina and was told in December that she'd be seen at a specialist cardiology clinic within three months. She's still waiting.

Annual conference of Interventional Cardiology Council begins

The U.S. Food and Drug Administration (FDA) has approved Incyte’s (NASDAQ:INCY) Pemazyre (pemigatinib), a selective fibroblast growth factor receptor (FGFR) inhibitor, for the treatment of adults with relapsed or refractory myeloid/lymphoid neoplasms (MLNs) with FGFR1 rearrangement. Incyte shares traded in a range of $71.38 to $72.98 on day volume of 1.25…